104 related articles for article (PubMed ID: 1975882)
1. Polymorphic sulphoxidation of carbocisteine.
Meese CO; Hofmann U; Eichelbaum M
Lancet; 1990 Sep; 336(8716):693-4. PubMed ID: 1975882
[No Abstract] [Full Text] [Related]
2. Carbocisteine sulphoxidation phenotype.
Waring RH; Mitchell SC
Lancet; 1990 Jun; 335(8704):1527. PubMed ID: 1972452
[No Abstract] [Full Text] [Related]
3. Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.
Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
Biochem Pharmacol; 1982 Oct; 31(19):3151-4. PubMed ID: 7150344
[No Abstract] [Full Text] [Related]
4. Genetically determined impaired drug sulphoxidation.
Waring RH; Mitchell SC; Idle JR; Smith RL
Lancet; 1981 Apr; 1(8223):778. PubMed ID: 6110975
[No Abstract] [Full Text] [Related]
5. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.
Waring RH; Mitchell SC; O'Gorman J; Fraser M
Biochem Pharmacol; 1986 Sep; 35(18):2999-302. PubMed ID: 3753512
[No Abstract] [Full Text] [Related]
6. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.
Mitchell SC; Waring RH; Haley CS; Idle JR; Smith RL
Br J Clin Pharmacol; 1984 Oct; 18(4):507-21. PubMed ID: 6487492
[TBL] [Abstract][Full Text] [Related]
7. The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine.
Mitchell SC; Waring RH
Pharmacol Ther; 1989; 43(2):237-49. PubMed ID: 2675135
[No Abstract] [Full Text] [Related]
8. Poor sulphoxidation in primary biliary cirrhosis.
Olomu A; Clements D; Waring R; Elias E
Lancet; 1985 Jun; 1(8444):1504. PubMed ID: 2861427
[No Abstract] [Full Text] [Related]
9. An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.
Karim EF; Millership JS; Temple DJ; Woolfson AD
Eur J Drug Metab Pharmacokinet; 1988; 13(4):253-6. PubMed ID: 3243319
[TBL] [Abstract][Full Text] [Related]
10. Does sulphoxidation state predict gold toxicity in rheumatoid arthritis?
Madhok R; Capell HA; Waring R
Br Med J (Clin Res Ed); 1987 Feb; 294(6570):483. PubMed ID: 3103737
[No Abstract] [Full Text] [Related]
11. False positives with current carbocisteine protocol for sulphoxidation phenotyping.
Küpfer A; Idle JR
Lancet; 1990 May; 335(8697):1107. PubMed ID: 1970413
[No Abstract] [Full Text] [Related]
12. Variation in human metabolism of S-carboxymethylcysteine.
Waring RH
Eur J Drug Metab Pharmacokinet; 1980; 5(1):49-52. PubMed ID: 7389752
[TBL] [Abstract][Full Text] [Related]
13. HPLC-analysis of S-carboxymethylcysteine and its sulphoxide metabolites.
Brockmöller J; Simane ZJ; Roots I
Drug Metabol Drug Interact; 1988; 6(3-4):447-56. PubMed ID: 3271650
[No Abstract] [Full Text] [Related]
14. Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis.
Davies MH; Ngong JM; Pean A; Vickers CR; Waring RH; Elias E
J Hepatol; 1995 May; 22(5):551-60. PubMed ID: 7650336
[TBL] [Abstract][Full Text] [Related]
15. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH
J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
[TBL] [Abstract][Full Text] [Related]
16. [The bioavailability and pharmacokinetics of two carbocysteine preparations after single and multiple dosing].
Lutz D; Gielsdorf W; Rasper J; Jaeger H; Albring M; Eisler G; Niebch G
Arzneimittelforschung; 1985; 35(1):163-6. PubMed ID: 4039146
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.
Brockmöller J; Staffeldt B; Roots I
Eur J Clin Pharmacol; 1991; 40(4):387-92. PubMed ID: 2050173
[TBL] [Abstract][Full Text] [Related]
18. Impaired sulfoxidation in primary biliary cirrhosis.
Elias E; Waring R
Hepatology; 1989 Dec; 10(6):1027. PubMed ID: 2583682
[No Abstract] [Full Text] [Related]
19. Identification of the "major" polymorphic carbocysteine metabolite as S-(carboxymethylthio)-L-cysteine.
Meese CO; Fischer C; Küpfer A; Wisser H; Eichelbaum M
Biochem Pharmacol; 1991 Oct; 42(10):R13-6. PubMed ID: 1741762
[No Abstract] [Full Text] [Related]
20. Experimental and clinical studies in otitis media with effusion: the role of carbocisteine.
Khan JA
J Laryngol Otol Suppl; 1983; 7():1-27. PubMed ID: 6363583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
